Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Giunchi

Showing results (41-50 of 112) with videos related to

Pageof 12
Sort By:
International Urology and Nephrology|November 25, 2021
Evaluating the performance of clinical and radiological data in predicting prostate cancer in prostate imaging reporting and data system version 2.1 category 3 lesions of the peripheral and the transition zonesCaterina Gaudiano, Lorenzo Bianchi, Beniamino Corcioni, et al.
Therapeutic Advances in Medical Oncology|December 10, 2020
Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation studyCostantino Ricci, Elisa Capizzi, Francesca Giunchi, et al.
Pathology|March 30, 2016
Renal oncocytosis: a clinicopathological and cytogenetic study of 42 tumours occurring in 11 patientsFrancesca Giunchi, Michelangelo Fiorentino, Valerio Vagnoni, et al.
Pathology, Research and Practice|February 8, 2021
Broad spectrum mutational analysis of chromophobe renal cell carcinoma using next-generation sequencingVeronica Mollica, Tania Franceschini, Elisa Gruppioni, et al.
Frontiers in Oncology|February 24, 2023
Case report: PSMA PET/CT addresses the correct diagnosis in a patient with metastatic prostate cancer despite negative core biopsies and mpMRI. A diagnostic challengeLuigia Vetrone, Giulia Cuzzani, Riccardo Mei, et al.
Cells|September 11, 2020
Is There a Role for Immunotherapy in Prostate Cancer?Alessandro Rizzo, Veronica Mollica, Alessia Cimadamore, et al.
Pathology, Research and Practice|January 26, 2024
Chromosome 3p gene alterations as biomarkers for immunocombinations in metastatic renal cell carcinoma: A hypothesis-generating analysisMatteo Rosellini, Veronica Mollica, Andrea Marchetti, et al.
Frontiers in Oncology|June 21, 2023
Multiparametric magnetic resonance imaging for the differential diagnosis between granulomatous prostatitis and prostate cancer: a literature review to an intriguing diagnostic challengeCaterina Gaudiano, Benedetta Renzetti, Cristina De Fino, et al.
Expert Review of Molecular Diagnostics|June 19, 2018
Biomarkers of aggressiveness in genitourinary tumors with emphasis on kidney, bladder, and prostate cancerAlessia Cimadamore, Silvia Gasparrini, Matteo Santoni, et al.
Pathology, Research and Practice|June 25, 2022
A hypothesis-generating analysis on the role of TERT promoter mutation in advanced urothelial carcinoma treated with immunotherapyPaola Valeria Marchese, Veronica Mollica, Dario De Biase, et al.
Pageof 12

Showing results (41-50 of 112) with videos related to

Sort By:
Pageof 12
International Urology and Nephrology|November 25, 2021
Evaluating the performance of clinical and radiological data in predicting prostate cancer in prostate imaging reporting and data system version 2.1 category 3 lesions of the peripheral and the transition zonesCaterina Gaudiano, Lorenzo Bianchi, Beniamino Corcioni, et al.
Therapeutic Advances in Medical Oncology|December 10, 2020
Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation studyCostantino Ricci, Elisa Capizzi, Francesca Giunchi, et al.
Pathology|March 30, 2016
Renal oncocytosis: a clinicopathological and cytogenetic study of 42 tumours occurring in 11 patientsFrancesca Giunchi, Michelangelo Fiorentino, Valerio Vagnoni, et al.
Pathology, Research and Practice|February 8, 2021
Broad spectrum mutational analysis of chromophobe renal cell carcinoma using next-generation sequencingVeronica Mollica, Tania Franceschini, Elisa Gruppioni, et al.
Frontiers in Oncology|February 24, 2023
Case report: PSMA PET/CT addresses the correct diagnosis in a patient with metastatic prostate cancer despite negative core biopsies and mpMRI. A diagnostic challengeLuigia Vetrone, Giulia Cuzzani, Riccardo Mei, et al.
Cells|September 11, 2020
Is There a Role for Immunotherapy in Prostate Cancer?Alessandro Rizzo, Veronica Mollica, Alessia Cimadamore, et al.
Pathology, Research and Practice|January 26, 2024
Chromosome 3p gene alterations as biomarkers for immunocombinations in metastatic renal cell carcinoma: A hypothesis-generating analysisMatteo Rosellini, Veronica Mollica, Andrea Marchetti, et al.
Frontiers in Oncology|June 21, 2023
Multiparametric magnetic resonance imaging for the differential diagnosis between granulomatous prostatitis and prostate cancer: a literature review to an intriguing diagnostic challengeCaterina Gaudiano, Benedetta Renzetti, Cristina De Fino, et al.
Expert Review of Molecular Diagnostics|June 19, 2018
Biomarkers of aggressiveness in genitourinary tumors with emphasis on kidney, bladder, and prostate cancerAlessia Cimadamore, Silvia Gasparrini, Matteo Santoni, et al.
Pathology, Research and Practice|June 25, 2022
A hypothesis-generating analysis on the role of TERT promoter mutation in advanced urothelial carcinoma treated with immunotherapyPaola Valeria Marchese, Veronica Mollica, Dario De Biase, et al.
Pageof 12